SEOM clinical guideline thyroid cancer (2019)
Por:
Gallardo, E, Medina, J, Sanchez, JC, Viudez, A, Grande, E, Porras, I, Cajal, TRY, Trigo, J, Iglesias, L, Capdevila, J
Publicada:
1 feb 2020
Resumen:
Thyroid carcinoma is the most frequent endocrine malignancy and accounts for around 3% of global cancer incidence. Different histologies and clinical scenarios make necessary a multidisciplinary approach that includes new diagnostic methods and surgical, radiopharmaceutical and systemic therapies. This guideline updates several aspects of management of thyroid cancer.
Filiaciones:
Gallardo, E:
Univ Autonoma Barcelona, Parc Tauli Hosp Univ, Inst Invest Innovacio Parc Tauli I3PT, Oncol Dept, E-08208 Barcelona, Spain
Medina, J:
Hosp Virgen Salud, Oncol Dept, Toledo, Spain
Sanchez, JC:
Hosp Univ Puerta Hierro, Oncol Dept, Madrid, Spain
Viudez, A:
Complejo Hosp Navarra, Oncol Dept, Pamplona, Spain
Grande, E:
MD Anderson Canc Ctr, Oncol Dept, Madrid, Spain
Porras, I:
Hosp Univ Reina Sofia, Oncol Dept, Cordoba, Spain
Cajal, TRY:
Hosp Santa Creu & Sant Pau, Oncol Dept, Barcelona, Spain
Trigo, J:
Hosp Univ Reg Virgen Victoria, Oncol Dept, Malaga, Spain
Iglesias, L:
Hosp Univ 12 Octubre, Oncol Dept, Madrid, Spain
Capdevila, J:
Hosp Univ Vall dHebron, Vall Hebron Inst Oncol, Oncol Dept, Barcelona, Spain
Hybrid Gold
|